Comment
Author: Admin | 2025-04-28
Stearate both increase QTc interval. Avoid or Use Alternate Drug.quetiapineerythromycin stearate will increase the level or effect of quetiapine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.quinidineerythromycin stearate will increase the level or effect of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.quinupristin/dalfopristinquinupristin/dalfopristin will increase the level or effect of erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.quinupristin/dalfopristin increases levels of erythromycin stearate by decreasing metabolism. Contraindicated. Risk of prolonged QTc interval.ranolazineerythromycin stearate will increase the level or effect of ranolazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.repaglinideerythromycin stearate will increase the level or effect of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.repotrectiniberythromycin stearate will increase the level or effect of repotrectinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Discontinue strong or moderate CYP3A inhibitors and wait 3-5 elimination half-lives before initiating repotrectinib. erythromycin stearate will increase the level or effect of repotrectinib by P-glycoprotein (MDR1) efflux transporter. Avoid or Use Alternate Drug.resmetiromerythromycin stearate will increase the level or effect of resmetirom by Other (see comment). Avoid or Use Alternate Drug. Avoid coadministration of resmetirom (an OATP1B1/3 substrate) with OATP1B1/3 inhibitors.revefenacinerythromycin stearate increases levels of revefenacin by Other (see comment). Avoid or Use Alternate Drug. Comment: OATP1B1 and OATP1B3 transport inhibitors may increase systemic exposure of revefenacin's active metabolite. Coadministration not recommended.ribociclibribociclib increases toxicity of erythromycin stearate by QTc interval. Avoid or Use Alternate Drug.rifabutinerythromycin stearate increases levels of rifabutin by decreasing metabolism. Contraindicated.rifabutin will decrease the level or effect of erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.rifampinrifampin will decrease the level or effect of erythromycin stearate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.rifapentinerifapentine will
Add Comment